Evidence map›Paper›PMID 32416175›Full record

ArticleThe American journal of medicine2020

Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response Team.

Brett J Carroll, Sebastian E Beyer, Tyler Mehegan, Andrew Dicks, Abby Pribish, Andrew Locke, Anuradha Godishala, Kevin Soriano, Jaya Kanduri, Kelsey Sack and 10 more

Open access · greenAbstract read
In one paragraph

Article in The American journal of medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis.Clinical research in cardiology : official journal of the German Cardiac Society · 2023
    Pooled it
  2. Impact of pulmonary embolism response teams on acute pulmonary embolism: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2022
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Observational
  18. Interventional therapies for pulmonary embolism.Nature reviews. Cardiology · 2023
    Review
  19. Article
  20. Percutaneous Management of High-Risk Pulmonary Embolism.Circulation. Cardiovascular interventions · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 2 countries.

Brett J CarrollDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass. Electronic address: bcarrol2@bidmc.harvard.edu.
Sebastian E BeyerDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Tyler MeheganDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Andrew DicksDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Abby PribishDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Andrew LockeDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Anuradha GodishalaDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Kevin SorianoDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Jaya KanduriDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Kelsey SackDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Inbar RaberDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Cara WiestDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Isabel BalachandranDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Mason MarcusDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Louis ChuDivision of Cardiac Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Margaret M HayesDivision of Pulmonary and Critical Care Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Jeff L WeinsteinDivision of Interventional Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Kenneth A BauerDivision of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Eric A SecemskyDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Duane S PintoDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Beth Israel Deaconess Medical Center · USHadassah Medical Center · IL

Funding

Shared Decision-Making to Improve the Health Status of Patients with Claudication: Developing and Implementing Strategies to Individualize Treatment DecisionsK23HL150290 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SECEMSKY, ERIC ALEXANDER · 2020 to 2024
$851k
NHLBI NIH HHS K23 HL150290
6 · The paper itself

Abstract

backgroundOptimal management of acute pulmonary embolism requires expertise offered by multiple subspecialties. As such, pulmonary embolism response teams (PERTs) have increased in prevalence, but the institutional consequences of a PERT are unclear.

methodsWe compared all patients that presented to our institution with an acute pulmonary embolism in the 3 years prior to and 3 years after the formation of our PERT. The primary outcome was in-hospital pulmonary embolism-related mortality before and after the formation of the PERT. Sub-analyses were performed among patients with elevated-risk pulmonary embolism.

resultsBetween August 2012 and August 2018, 2042 patients were hospitalized at our institution with acute pulmonary embolism, 884 (41.3%) pre-PERT implementation and 1158 (56.7%) post-PERT implementation, of which 165 (14.2%) were evaluated by the PERT. There was no difference in pulmonary embolism-related mortality between the two time periods (2.6% pre-PERT implementation vs 2.9% post-PERT implementation, P = .89). There was increased risk stratification assessment by measurement of cardiac biomarkers and echocardiograms post-PERT implementation. Overall utilization of advanced therapy was similar between groups (5.4% pre-PERT implementation vs 5.4% post-PERT implementation, P = 1.0), with decreased use of systemic thrombolysis (3.8% pre-PERT implementation vs 2.1% post-PERT implementation, P = 0.02) and increased catheter-directed therapy (1.3% pre-PERT implementation vs 3.3% post-PERT implementation, P = 0.05) post-PERT implementation. Inferior vena cava filter use decreased after PERT implementation (10.7% pre-PERT implementation vs 6.9% post-PERT implementation, P = 0.002). Findings were similar when analyzing elevated-risk patients.

conclusionPulmonary embolism response teams may increase risk stratification assessment and alter application of advanced therapies, but a mortality benefit was not identified.

Indexed as

Hospital MortalityPatient Care TeamReferral and ConsultationAgedCause of DeathEchocardiographyEmbolectomyErythrocyte TransfusionExtracorporeal Membrane OxygenationFemaleHeart VentriclesHemorrhageHumansIntracranial HemorrhagesLength of StayLogistic ModelsNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Catheter-directed thrombolysisInferior vena cava filters, Pulmonary embolism, Response teams, Systemic thrombolysis

Identifiers

PMID32416175
PMCPMC8076889
OpenAlexW3026144585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.